Valeo Financial Advisors, LLC Agenus Inc Transaction History

Valeo Financial Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$2.56 - $5.49 $128 - $274	-50 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$3.17 - $4.49 $158 - $224	50 New	50 $0
Q3 2020 Oct 28, 2020	SELL	$2.98 - $5.2 $1,490 - $2,600	-500 Closed	0 $0
Q1 2020 Apr 13, 2020	BUY	$1.92 - $4.39 $960 - $2,195	500 New	500 $1,000
Q2 2018 Aug 14, 2018	SELL	$2.26 - $4.65 $677 - $1,395	-300 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$3.26 - $4.78 $977 - $1,434	300	300 $1,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.